• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

路易体百年(1912-2012)。

Centenary of Lewy bodies (1912-2012).

机构信息

Department of Neurology, Schlossparkklinik Berlin, Grolmanstr. 56, 10623, Berlin, Germany.

出版信息

J Neural Transm (Vienna). 2013 Apr;120(4):509-16. doi: 10.1007/s00702-013-0984-2. Epub 2013 Mar 2.

DOI:10.1007/s00702-013-0984-2
PMID:23456291
Abstract

During the years from 1908 until 1923, Lewy was the first to detail the pathological anatomy of Parkinson's disease, leading to his seminal contribution in 1912 describing the neuronal eosinophilic cytoplasmatic concentric inclusion bodies in the brainstem, later accomplished by more systematic investigations in 1923 (Lewy in Lewandowsky's Handbuch der Neurologie, 3. Band: Spez. Neurologie II. Springer, Berlin, pp 920-933, 1912). With the exception of a minority of cases and those that displayed postencephalitic Parkinsonism, Lewy was not able to confirm the significance of the substantia nigra. The findings of Tretiakoff in 1919 (significance of the substantia nigra in PD and coining of the term 'Corps de Lewy') have been underestimated or ignored for a long time. In a historical review on basal ganglia diseases from 1942, Lewy stressed the histological abnormalities of the basal ganglia and their diffuse distribution but not expressly the inclusion bodies, which in his former studies were unique in PD. For Lewy this finding was not a characteristic of the disease. Subsequent to his expulsion from Nazi-Germany in 1933, Lewy never resumed his research on PD. At the time of Lewy's death in 1950, the era of the Lewy bodies, Lewy-body-disease and the identification of atypical Parkinson syndrome cases had not even begun and followed much later.

摘要

从 1908 年到 1923 年,Lewy 首次详细描述了帕金森病的病理学解剖,这导致了他在 1912 年的开创性贡献,描述了脑干中神经元嗜酸性细胞质同心包涵体,后来在 1923 年通过更系统的调查得以证实(Lewy 在 Lewandowsky 的 Handbuch der Neurologie,第 3 卷:Spez. Neurologie II. Springer,Berlin,pp 920-933,1912)。除了少数病例和那些表现出脑炎后帕金森病的病例外,Lewy 无法确认黑质的重要性。Tretiaoff 在 1919 年的发现(黑质在 PD 中的意义和术语“Lewy 体”的创造)长期以来被低估或忽视。在 1942 年关于基底神经节疾病的历史回顾中,Lewy 强调了基底神经节的组织学异常及其弥漫性分布,但没有明确提到包涵体,在他以前的研究中,包涵体是 PD 的独特特征。对 Lewy 来说,这一发现不是疾病的特征。1933 年他被纳粹德国驱逐后,Lewy 从未恢复对 PD 的研究。到 1950 年 Lewy 去世时,Lewy 体、Lewy 体病和非典型帕金森综合征病例的识别时代甚至还没有开始,更不用说后来了。

相似文献

1
Centenary of Lewy bodies (1912-2012).路易体百年(1912-2012)。
J Neural Transm (Vienna). 2013 Apr;120(4):509-16. doi: 10.1007/s00702-013-0984-2. Epub 2013 Mar 2.
2
Centenary of Tretiakoff's thesis on the morphology of Parkinson's disease, evolved on the grounds of encephalitis lethargica pathology.特里亚科夫关于帕金森病形态学的论文发表一百周年,该论文基于昏睡性脑炎病理学发展而来。
J Hist Neurosci. 2019 Oct-Dec;28(4):387-398. doi: 10.1080/0964704X.2019.1622361. Epub 2019 Jun 21.
3
Friedrich Heinrich Lewy (1885-1950) and his work.弗里德里希·海因里希·路易(1885 - 1950)及其著作。
J Hist Neurosci. 2002 Mar;11(1):19-28. doi: 10.1076/jhin.11.1.19.9106.
4
TIGAR inclusion pathology is specific for Lewy body diseases.TIGAR 包涵体病理学是路易体病的特征。
Brain Res. 2019 Mar 1;1706:218-223. doi: 10.1016/j.brainres.2018.09.032. Epub 2018 Sep 26.
5
A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.黑质中存在稳定比例的路易体神经元提示路易体导致神经元死亡的模型。
Neurobiol Aging. 2010 Jan;31(1):99-103. doi: 10.1016/j.neurobiolaging.2008.03.015. Epub 2008 May 23.
6
Intraneuronal Lewy body inclusions in Parkinson and diffuse Lewy body disease.帕金森病和弥漫性路易体病中的神经元内路易小体包涵体
J Cell Mol Med. 2001 Jul-Sep;5(3):318-9. doi: 10.1111/j.1582-4934.2001.tb00166.x.
7
Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?路易体痴呆与帕金森病痴呆:它们有区别吗?
Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S47-51. doi: 10.1016/j.parkreldis.2004.10.014.
8
The Lewy body in Parkinson's disease.帕金森病中的路易小体。
Adv Neurol. 1987;45:35-43.
9
TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease.散发性帕金森病中路易小体内的TorsinA积聚。
Brain Res. 2000 Sep 22;877(2):379-81. doi: 10.1016/s0006-8993(00)02702-5.
10
Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.黑质神经元中与路易体相关疾病及正常衰老过程中的凋亡样变化。
Am J Pathol. 1997 Jan;150(1):119-31.

引用本文的文献

1
Frederic Lewy: how the two World Wars changed his life, work, and name.弗雷德里克·卢伊:两次世界大战如何改变了他的生活、工作和名字。
Arq Neuropsiquiatr. 2024 Mar;82(3):1-2. doi: 10.1055/s-0044-1779692. Epub 2024 Mar 11.
2
[Persecuted and forgotten? The neurologists Kurt Goldstein and Friedrich Heinrich Lewy].[被迫害与被遗忘?神经学家库尔特·戈尔茨坦和弗里德里希·海因里希·洛伊]
Nervenarzt. 2022 Oct;93(Suppl 1):32-41. doi: 10.1007/s00115-022-01312-3. Epub 2022 Oct 5.
3
Insights Into the Role of Mortalin in Alzheimer's Disease, Parkinson's Disease, and HIV-1-Associated Neurocognitive Disorders.

本文引用的文献

1
Who was the man who discovered the "Lewy bodies"?谁发现了“路易体”?
Mov Disord. 2010 Sep 15;25(12):1765-73. doi: 10.1002/mds.22956.
2
The black stuff and Konstantin Nikolaevich Tretiakoff.黑色物质与康斯坦丁·尼古拉耶维奇·特雷蒂亚科夫
Mov Disord. 2008 Apr 30;23(6):777-83. doi: 10.1002/mds.21855.
3
Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered.2005年斯坦利·法恩讲座:对散发性帕金森病相关包涵体病理学分期程序的重新审视。
深入了解mortalin在阿尔茨海默病、帕金森病和HIV-1相关神经认知障碍中的作用。
Front Cell Dev Biol. 2022 Jul 4;10:903031. doi: 10.3389/fcell.2022.903031. eCollection 2022.
4
Parkinson's disease and mitophagy: an emerging role for LRRK2.帕金森病与线粒体自噬:LRRK2 的新作用
Biochem Soc Trans. 2021 Apr 30;49(2):551-562. doi: 10.1042/BST20190236.
5
Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study.帕金森病全诊所研究招募:神经诊断中的分子综合 (MIND) 研究。
J Parkinsons Dis. 2021;11(2):757-765. doi: 10.3233/JPD-202406.
6
Parkinson's disease and translational research.帕金森病与转化研究。
Transl Neurodegener. 2020 Dec 1;9(1):43. doi: 10.1186/s40035-020-00223-0.
7
Biological bases for a possible effect of cannabidiol in Parkinson's disease.大麻二酚在帕金森病中可能产生作用的生物学基础。
Braz J Psychiatry. 2020 Apr;42(2):218-224. doi: 10.1590/1516-4446-2019-0460. Epub 2019 Jul 15.
8
α-Synuclein in Parkinson's disease: causal or bystander?α-突触核蛋白在帕金森病中的作用:是病因还是旁观者?
J Neural Transm (Vienna). 2019 Jul;126(7):815-840. doi: 10.1007/s00702-019-02025-9. Epub 2019 Jun 25.
9
Lewy and his inclusion bodies: Discovery and rejection.路易与他的包涵体:发现与否定。
Dement Neuropsychol. 2017 Apr-Jun;11(2):198-201. doi: 10.1590/1980-57642016dn11-020012.
10
Extract Delays the Development of Motor Signs and Prevents Dopaminergic Loss in a Mice Model of Parkinson's Disease.提取物延缓帕金森病小鼠模型运动症状的发展并防止多巴胺能神经元丢失。
Evid Based Complement Alternat Med. 2017;2017:8429290. doi: 10.1155/2017/8429290. Epub 2017 Aug 1.
Mov Disord. 2006 Dec;21(12):2042-51. doi: 10.1002/mds.21065.
4
Fritz Heinrich Lewy (1885-1950).弗里茨·海因里希·路易(1885 - 1950)。
J Neurol. 2006 May;253(5):677-8. doi: 10.1007/s00415-006-0130-2.
5
The brain-stem lesions in Parkinsonism.帕金森病中的脑干病变。
J Neurol Neurosurg Psychiatry. 1953 Nov;16(4):213-26. doi: 10.1136/jnnp.16.4.213.
6
Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).与特发性帕金森病相关的脑内包涵体病理学分期(临床前期和临床期)
J Neurol. 2002 Oct;249 Suppl 3:III/1-5. doi: 10.1007/s00415-002-1301-4.
7
Friedrich Heinrich Lewy (1885-1950) and his work.弗里德里希·海因里希·路易(1885 - 1950)及其著作。
J Hist Neurosci. 2002 Mar;11(1):19-28. doi: 10.1076/jhin.11.1.19.9106.
8
alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.来自帕金森病和路易体痴呆患者路易小体丝状包涵体中的α-突触核蛋白。
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6469-73. doi: 10.1073/pnas.95.11.6469.
9
Alpha-synuclein in Lewy bodies.路易小体中的α-突触核蛋白。
Nature. 1997 Aug 28;388(6645):839-40. doi: 10.1038/42166.
10
What's in a name? Dr. Lewey and the Lewy body.名字里有什么?勒维医生与路易小体。
Neurology. 1997 Aug;49(2):629-30. doi: 10.1212/wnl.49.2.629.